Also listed under Stomach Diseases
ClinicalTrials.gov term: Stomach Neoplasms
77 trials changed in the last 30 days: 3 stopped, 27 with notable changes, 47 with minor changes only.
Trial terminated
Also in this update: Final enrollment: 14 participants (planned 135)
Boehringer IngelheimPhase 1 NCT06882746 Registry history of NCT06882746 on ClinicalTrials.gov (opens the registry)
Trial terminated
Also in this update: Final enrollment: 3 participants — 3% of the 120 planned; Primary completion date changed from estimate of Sep 1, 2027 to Jan 30, 2026
SystImmune Inc.Phase 1 NCT06714617 Registry history of NCT06714617 on ClinicalTrials.gov (opens the registry)
Trial status changed: Active, Not Recruiting → Suspended
Also in this update: Primary and study completion pushed from Jun 2026 to Mar 2027
Weill Medical College of Cornell UniversityNot applicable NCT03623464 Registry history of NCT03623464 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Jun 30, 2026 to Oct 31, 2027
Toray Industries, IncPhase 2 NCT06038578 Registry history of NCT06038578 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from May 30, 2026 to Jun 30, 2027
Also in this update: Sponsor changed: Suzhou Transcenta Therapeutics Co., Ltd. to Transcenta Therapeutics (Hangzhou) Co., Ltd.; Study completion pushed from Nov 30, 2026 to Sep 30, 2027
Transcenta Therapeutics (Hangzhou) Co., Ltd.Phase 1/2 NCT04396821 Registry history of NCT04396821 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Jul 16, 2027 to Mar 16, 2029
Also in this update: Enrollment increased: 280 → 392 participants; Interventions modified
AstraZenecaPhase 1/2 NCT06005493 Registry history of NCT06005493 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Dec 31, 2026 to Dec 31, 2027
National Cancer Institute (NCI)Phase 2 NCT02465060 Registry history of NCT02465060 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Jun 2027 to Dec 31, 2028
Also in this update: Interventions modified
Cancer Research UKPhase 1/2 NCT05944237 Registry history of NCT05944237 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Jun 2026 to Jun 2027
Also in this update: Study completion pushed from Jun 2027 to Jun 2028
Fox Chase Cancer CenterPhase 1 NCT05274048 Registry history of NCT05274048 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Jan 1, 2028 to Jan 31, 2029
Also in this update: Trial status changed: Recruiting → Not Yet Recruiting; Study completion pushed from Jan 1, 2029 to Mar 31, 2029
Guangxi Medical UniversityNot applicable NCT07561073 Registry history of NCT07561073 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Dec 31, 2026 to Dec 1, 2028
Also in this update: Primary endpoint(s) modified; Recruitment opened
Peking University First HospitalNot specified NCT07039474 Registry history of NCT07039474 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Dec 1, 2025 to Dec 1, 2026
Also in this update: Trial status changed: Unknown → Recruiting; Study completion pushed from Dec 31, 2025 to Dec 31, 2026
Chinese University of Hong KongNot specified NCT04840056 Registry history of NCT04840056 on ClinicalTrials.gov (opens the registry)
Primary endpoint(s) modified
Also in this update: Phase changed: Phase 1/2 → Phase 1; Trial completed
Apollo Therapeutics LtdPhase 1 NCT06399757 Registry history of NCT06399757 on ClinicalTrials.gov (opens the registry)
Enrollment reduced: 30 → 9 participants
Also in this update: Trial status changed: Enrolling by Invitation → Recruiting; Interventions modified
wangdongshengNot applicable NCT07708012 Registry history of NCT07708012 on ClinicalTrials.gov (opens the registry)
Sponsor changed: Suzhou Transcenta Therapeutics Co., Ltd. to Transcenta Therapeutics (Hangzhou) Co., Ltd.
Transcenta Therapeutics (Hangzhou) Co., Ltd.Phase 3 NCT06093425 Registry history of NCT06093425 on ClinicalTrials.gov (opens the registry)
Recruitment opened
TJ Biopharma Co., Ltd.Phase 1 NCT07715747 Registry history of NCT07715747 on ClinicalTrials.gov (opens the registry)
Recruitment opened
Also in this update: Trial sites expanded: 0 → 3 locations; Start date changed from estimate of Sep 1, 2026 to Sep 14, 2026
AbbViePhase 1 NCT07807956 Registry history of NCT07807956 on ClinicalTrials.gov (opens the registry)
Recruitment opened
AkesoPhase 3 NCT07700979 Registry history of NCT07700979 on ClinicalTrials.gov (opens the registry)
Recruitment opened
Hua Huang, MD, PhDPhase 3 NCT07789184 Registry history of NCT07789184 on ClinicalTrials.gov (opens the registry)
Recruitment opened
Also in this update: Primary completion pushed from Jul 15, 2029 to Sep 15, 2029; Study completion pushed from Jul 15, 2030 to Sep 15, 2030
XYone Therapeutics, IncPhase 1/2 NCT07670312 Registry history of NCT07670312 on ClinicalTrials.gov (opens the registry)
Trial status changed: Unknown → Completed
Also in this update: Interventions modified; Start date changed from estimate of Sep 10, 2024 to Sep 30, 2024; and 1 more change in the last 30 days
AkesoPhase 1/2 NCT06586294 Registry history of NCT06586294 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Jul 31, 2026 to Dec 31, 2026
BicycleTx LimitedPhase 1/2 NCT04180371 Registry history of NCT04180371 on ClinicalTrials.gov (opens the registry)
Trial completed
Toray Industries, IncPhase 1 NCT03872947 Registry history of NCT03872947 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Jun 30, 2026 to Nov 30, 2026
Also in this update: Enrollment increased: 115 → 160 participants; Study completion pushed from Dec 30, 2026 to Dec 30, 2028
Medicenna Therapeutics, Inc.Phase 1/2 NCT05086692 Registry history of NCT05086692 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Primary completion date changed from estimate of Jan 31, 2025 to May 31, 2025; Final enrollment: 409 participants (planned 300)
Chinese PLA General HospitalNot specified NCT06798376 Registry history of NCT06798376 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Also in this update: Study completion moved earlier from Dec 2028 to Dec 2027; Primary completion date changed from estimate of Dec 2026 to Aug 20, 2026
Georgetown UniversityPhase 3 NCT05482516 Registry history of NCT05482516 on ClinicalTrials.gov (opens the registry)
Enrollment increased: 285 → 330 participants
ModeX Therapeutics, An OPKO Health CompanyPhase 1/2 NCT06239194 Registry history of NCT06239194 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Primary completion date changed from estimate of Nov 6, 2027 to Feb 9, 2026; Final enrollment: 430 participants (planned 500)
University of MiamiPhase 4 NCT07224035 Registry history of NCT07224035 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Primary completion date changed from estimate of Nov 6, 2027 to Apr 14, 2026; Final enrollment: 50 participants (planned 75)
University of MiamiPhase 4 NCT07224048 Registry history of NCT07224048 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 16 → 19 locations
SOFIEPhase 3 NCT07217704 Registry history of NCT07217704 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Primary completion date changed from estimate of Apr 30, 2026 to Jul 30, 2026
Medizinische Hochschule Brandenburg Theodor FontaneNot specified NCT06902337 Registry history of NCT06902337 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 311 → 314 locations
AstraZenecaPhase 3 NCT07431281 Registry history of NCT07431281 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Aug 30, 2026 to Sep 30, 2026
Peking UniversityPhase 2/3 NCT03691454 Registry history of NCT03691454 on ClinicalTrials.gov (opens the registry)
Enrollment increased: 100 → 120 participants
National Cancer Institute (NCI)Phase 1 NCT06885697 Registry history of NCT06885697 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 11 → 16 locations
Perspective TherapeuticsPhase 1/2 NCT06710756 Registry history of NCT06710756 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 91 → 94 locations
Daiichi SankyoPhase 2 NCT06172478 Registry history of NCT06172478 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 10 → 35 locations
Eikon TherapeuticsPhase 1/2 NCT07262619 Registry history of NCT07262619 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 12 → 15 locations
Gilead SciencesPhase 2 NCT07546812 Registry history of NCT07546812 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 3 → 7 locations
Avacta Life Sciences LtdPhase 1 NCT07454642 Registry history of NCT07454642 on ClinicalTrials.gov (opens the registry)
Primary completion date changed from estimate of Aug 31, 2027 to Jun 30, 2026
GlaxoSmithKlinePhase 1 NCT05277051 Registry history of NCT05277051 on ClinicalTrials.gov (opens the registry)
Study completion moved earlier from Jan 14, 2033 to Jul 21, 2032
Also in this update: Primary completion moved earlier from Jan 15, 2032 to Jul 22, 2031; and 3 more changes in the last 30 days
PfizerPhase 2/3 NCT07392892 Registry history of NCT07392892 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 793 → 798 locations
Alliance for Clinical Trials in OncologyPhase 3 NCT05677490 Registry history of NCT05677490 on ClinicalTrials.gov (opens the registry)
Study completion pushed from Dec 31, 2026 to Nov 30, 2027
Also in this update: Primary completion date changed from estimate of Dec 31, 2026 to Nov 30, 2025
Klus Pharma Inc.Phase 1/2 NCT04152499 Registry history of NCT04152499 on ClinicalTrials.gov (opens the registry)
Study completion pushed from Sep 30, 2026 to Mar 31, 2027
Astellas Pharma Global Development, Inc.Phase 3 NCT03653507 Registry history of NCT03653507 on ClinicalTrials.gov (opens the registry)
Primary completion date changed from estimate of Sep 30, 2026 to Jul 15, 2026
Jazz PharmaceuticalsPhase 3 NCT05152147 Registry history of NCT05152147 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 364 → 368 locations
Alliance for Clinical Trials in OncologyNot applicable NCT07283939 Registry history of NCT07283939 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 18 → 23 locations
Alliance for Clinical Trials in OncologyNot applicable NCT07059884 Registry history of NCT07059884 on ClinicalTrials.gov (opens the registry)
Primary completion date changed from estimate of Sep 28, 2026 to Aug 14, 2026
AstraZenecaPhase 2 NCT07143604 Registry history of NCT07143604 on ClinicalTrials.gov (opens the registry)
Study completion pushed from Sep 30, 2026 to Oct 30, 2026
Xijing HospitalPhase 2 NCT06576921 Registry history of NCT06576921 on ClinicalTrials.gov (opens the registry)
Primary completion date changed from estimate of Dec 23, 2026 to Apr 15, 2026
USWM CT, LLCPhase 1 NCT04044859 Registry history of NCT04044859 on ClinicalTrials.gov (opens the registry)
Start date changed from estimate of Sep 22, 2026 to Sep 8, 2026
Novartis PharmaceuticalsPhase 1 NCT07801508 Registry history of NCT07801508 on ClinicalTrials.gov (opens the registry)
Study completion pushed from May 30, 2030 to May 30, 2031
ECOG-ACRIN Cancer Research GroupPhase 2/3 NCT07001748 Registry history of NCT07001748 on ClinicalTrials.gov (opens the registry)
Registry marked status Unknown (sponsor has not verified the record since Aug 2023); last known: Recruiting
Chongqing Precision Biotech Co., LtdPhase 1 NCT06010862 Registry history of NCT06010862 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2023); last known: Active, Not Recruiting
Fujian Medical UniversityPhase 3 NCT04611997 Registry history of NCT04611997 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Not Yet Recruiting
Xianglin YuanPhase 1/2 NCT06592287 Registry history of NCT06592287 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Active, Not Recruiting
Yu jirenPhase 2 NCT04515615 Registry history of NCT04515615 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
First Affiliated Hospital of Zhejiang UniversityPhase 1 NCT04778839 Registry history of NCT04778839 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Enrolling by Invitation
Dong PengNot specified NCT06707714 Registry history of NCT06707714 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyNot specified NCT06653478 Registry history of NCT06653478 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
Xiangdong ChengNot specified NCT06642857 Registry history of NCT06642857 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Active, Not Recruiting
First Affiliated Hospital of Chongqing Medical UniversityNot specified NCT06606912 Registry history of NCT06606912 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Oct 2023); last known: Not Yet Recruiting
Royal Marsden NHS Foundation TrustNot specified NCT06057220 Registry history of NCT06057220 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
Fondazione Policlinico Universitario Agostino Gemelli IRCCSNot specified NCT05878964 Registry history of NCT05878964 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Feb 2022); last known: Recruiting
Second Affiliated Hospital of Xi'an Jiaotong UniversityNot specified NCT05291728 Registry history of NCT05291728 on ClinicalTrials.gov (opens the registry)
Changed
Registry verification sweep
Changed
Registry marked status Unknown (sponsor has not verified the record since Oct 2023); last known: Recruiting
Tianjin Medical University Cancer Institute and HospitalNot specified NCT06102785 Registry history of NCT06102785 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Oct 2023); last known: Recruiting
Tianjin Medical University Cancer Institute and HospitalNot specified NCT06102759 Registry history of NCT06102759 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Oct 2023); last known: Recruiting
Tianjin Medical University Cancer Institute and HospitalNot specified NCT06102772 Registry history of NCT06102772 on ClinicalTrials.gov (opens the registry)
Changed
Registry verification sweep
Changed
| First posted | Trial | Sponsor | Phase |
|---|---|---|---|
| 2026-10-19 | NCT07881133 Perioperative Biomarkers in Colorectal and Gastric Cancer Surgery | Bucharest Emergency Hospital new | |
| 2026-10-05 | NCT07858500 Zolbetuximab and Other Cancer Treatments in People With Advanced Gastric or GEJ Cancer in… | Astellas Pharma Europe Ltd. new | |
| 2026-10-05 | NCT07857668 LECS Combined With LSNNS for Early Gastric Cancer (LENS Trial) | Peking University People's Hospital new | |
| 2026-10-02 | NCT07856212 Maintenance Therapy in Metastatic Gastric Cancer: A Multicenter Retrospective Study in… | Fundación Santa Fe de Bogota new | |
| 2026-09-30 | NCT07850882 A Prospective Real-World Observational Study of Intratumoral Oncolytic Virus Injection… | Jie Yuan，MD new | |
| 2026-09-18 | NCT07829081 Research on Effective Strategies After Immunotherapy for Mismatch Repair-deficient… | University Hospital, Basel, Switzerland new | |
| 2026-09-17 | NCT07825870 Outcomes of Fluoroscopy-Guided Transdiscal Splanchnic Nerve Neurolysis for Upper… | Sahiwal medical college sahiwal new | |
| 2026-09-10 | NCT07814248 A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of… | TwoStep Therapeutics, Inc. new | Phase 1 |
| 2026-09-10 | NCT07812805 SKL35501 With SKL35502 Imaging in Adults With NTSR1 Positive Advanced Solid Tumors | SK Life Science, Inc. new | Phase 1 |
| 2026-09-08 | NCT07808164 ENPP1/cGAS (EG) and FAP Expression Profiles in Solid Tumors: An Immunohistochemical Study… | Tam Anh Research Institute new |
| Early Phase 1 | 19 | |
| Phase 1 | 128 | |
| Phase 1/2 | 105 | |
| Phase 2 | 277 | |
| Phase 2/3 | 23 | |
| Phase 3 | 78 | |
| Phase 4 | 15 |
Fudan University (32) · The First Affiliated Hospital with Nanjing Medical University (23) · National Cancer Institute (NCI) (19) · AstraZeneca (18) · Fujian Medical University (16) · Qilu Hospital of Shandong University (14) · Nanfang Hospital, Southern Medical University (13) · Ruijin Hospital (13) · Memorial Sloan Kettering Cancer Center (12) · M.D. Anderson Cancer Center (10)